What’s New with the FDA Labeling for Pregnancy and Lactation?
The Carlat Psychiatry Report, Volume 14, Number 7&8, July 2016
Talia Puzantian, PharmD, BCPP
Deputy Editor, The Carlat Psychiatry Report
Dr. Puzantian has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
We’ve been hearing for some time now about the FDA’s plans to revise the long-standing categories A, B, C, D, and X designations for risk of using medications in pregnancy. The new rule (referred to as PLLR for Pregnancy and Lactation Labeling Rule) was proposed in 2008, finalized in 2014, and implementation began during the summer of 2015.